Trial intelligence / Profile preview

Propranolol for Winter Depression

NCT00016666Phase 2Completed

Sponsor
National Institute of Mental Health
Start
May 2001
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of propranolol in Seasonal Affective Disorder (SAD) (2 arms), sponsored by National Institute of Mental Health. Primary endpoint: Improvement in depressive symptoms at 4 weeks. Started May 2001; status: completed.

02

Drugs

propranolol
03

Conditions

Seasonal Affective Disorder (SAD)

Beyond the preview

Go deeper on NCT00016666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00016666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call